Latest Breaking News On - Strengthen entheon - Page 1 : comparemela.com

Entheon Biomedical Corp. Announces Acquisition of HaluGen Life Sciences Inc. Vancouver, British Columbia (Newsfile Corp. - January 14, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1) ( Entheon or the Company ) is pleased to announce that the Company completed its acquisition of HaluGen Life Sciences Inc. ( HaluGen ), a biotech company in the business of developing and commercializing a pre-screening test to identify genetic markers predictive of an individual s reaction to hallucinogenic drugs. The Company acquired 100% of the issued and outstanding common shares in the capital of HaluGen (the HaluGen Shares ) from the shareholders of HaluGen (the HaluGen Shareholders ) pursuant to a share exchange agreement among the Company, HaluGen and the HaluGen Shareholders, resulting in HaluGen becoming a wholly-owned subsidiary of Entheon (the

United statesUnited kingdomBritish columbiaTimothy koJoseph cullenProduct development agreementHalugen life sciences incEntheon biomedical corpBritish columbia newsfile corpCompensation shares to lobo genetics incEuropean unionCanadian securities exchangeGenetic screening test technologyStrengthen entheonHalugen life sciencesHalugen shareholders